NR 341 Complex Adult Health Exam 1 Midterm Exam Prep
Document | 2026/2027 Edition | 200 Verified Questions
NR 341 Complex Adult Health Exam 1 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document covers Complex Adult Health Exam 1 for NR 341,
featuring 200 verified questions with detailed rationales. It is designed for nursing students seeking a
pass guarantee and A+ grading. Content reflects the latest 2026/2027 curriculum and clinical
guidelines. Each question includes evidence-based rationales to reinforce understanding of complex
adult health concepts.
Abstract:
NR 341 Complex Adult Health Exam 1 is a rigorous assessment of nursing students' ability to manage critically ill
adult patients. This document contains 200 actual exam questions from the 2026/2027 academic year, each with
detailed rationales that explain correct and incorrect answer choices. The content covers core areas such as
hemodynamic monitoring, mechanical ventilation, acute kidney injury, cardiac emergencies, neurological deficits,
and sepsis. Rationales are grounded in the latest evidence-based guidelines from organizations like the AACN and
AHA. This resource is designed to ensure students not only pass but achieve top scores by understanding the 'why'
behind each answer. It is ideal for self-study, group review, or as a supplement to course materials.
Content Area Overview:
Content Area Questions Key Topics Weight
Hemodynamics & Shock 1-40 Hemodynamic monitoring, shock 20%
classification, vasoactive medications, fluid
resuscitation
Respiratory Failure 41-80 ARDS, mechanical ventilation settings, 20%
ABG interpretation, weaning protocols
Renal & Electrolytes 81-120 Acute kidney injury, fluid/electrolyte 20%
imbalances, CRRT, acidosis/alkalosis
Cardiovascular Emergencies 121-150 ACS, dysrhythmias, cardiac tamponade, 15%
aortic dissection
Neurological Disorders 151-175 Stroke, intracranial pressure management, 12.5%
traumatic brain injury
Sepsis & MODS 176-200 Sepsis bundles, multi-organ dysfunction, 12.5%
vasopressors, steroids
Page 1
,Q1. A patient with septic shock remains hypotensive (MAP 58 mm Hg) despite norepinephrine at 30
mcg/min and vasopressin 0.04 units/min. Which intervention is most appropriate next?
A. Add dobutamine
B. Increase norepinephrine to 40 mcg/min
C. Start intravenous hydrocortisone
D. Add epinephrine infusion
Correct Answer: C. Start intravenous hydrocortisone
Rationale: Surviving Sepsis Campaign guidelines recommend intravenous hydrocortisone for
vasopressor-refractory septic shock. Dobutamine is indicated for low cardiac output, not as a
vasopressor. Increasing norepinephrine above moderate doses does not improve outcomes and may cause
adverse effects. Epinephrine is not first-line adjunct.
Why Wrong:
A - Dobutamine is not a vasopressor; it is used when cardiac output is low, which is not established.
B - Excessive norepinephrine doses increase risk of arrhythmias without proven benefit.
D - Epinephrine is reserved for anaphylaxis or refractory shock; not first-line adjunct for septic
shock.
Reference: Evans, L., et al. (2023). Surviving Sepsis Campaign: International Guidelines for
Management of Sepsis and Septic Shock 2021. Intensive Care Medicine.
Q2. A patient with ARDS on volume-controlled ventilation (FiO2 0.8, PEEP 12 cmH2O, tidal
volume 6 mL/kg PBW) has PaO2 70 mm Hg, PaCO2 48 mm Hg, pH 7.30. Which prescription is
anticipated, nonessential, or contraindicated?
A. Increase PEEP to 15 cmH2O
B. Administer cisatracurium infusion
C. Prone positioning
D. Decrease tidal volume to 4 mL/kg
Correct Answer: A. Increase PEEP to 15 cmH2O
Rationale: Increased PEEP (anticipated) may improve oxygenation; cisatracurium (anticipated) is
indicated for severe ARDS (PaO2/FiO2 <150); prone positioning (anticipated) improves oxygenation for
severe ARDS; decreasing Vt to 4 mL/kg is contraindicated as it worsens acidosis; inhaled nitric oxide is a
rescue therapy not routinely needed.
Reference: Thompson, B.T., et al. (2022). Acute Respiratory Distress Syndrome. New England Journal of
Medicine.
Page 2
,Q3. A patient with acute kidney injury stage 3 (serum creatinine 4.2 mg/dL, urine output <0.3
mL/kg/hr for 24 hours) has serum potassium of 6.8 mEq/L with broad QRS complexes on ECG.
Which intervention should be performed immediately?
A. Hemodialysis
B. Intravenous calcium gluconate
C. Sodium polystyrene sulfonate (Kayexalate)
D. Insulin and dextrose
Correct Answer: B. Intravenous calcium gluconate
Rationale: Calcium gluconate rapidly stabilizes the cardiac membrane in life-threatening hyperkalemia
with ECG changes. Insulin/dextrose and dialysis shift/remove potassium but are not first for acute
arrhythmia risk. Kayexalate is slow and not useful in emergency.
Why Wrong:
A - Hemodialysis effectively removes potassium but takes time to arrange; not the immediate
priority.
C - Sodium polystyrene sulfonate has delayed onset and is not indicated for acute hyperkalemia with
ECG changes.
D - Insulin and dextrose shifts potassium into cells but does not immediately protect the heart.
Reference: KDIGO. (2024). Clinical Practice Guideline for Acute Kidney Injury. Kidney International
Supplements.
Q4. A patient with septic shock develops widespread petechiae and bleeding from mucous
membranes. Which laboratory finding is most diagnostic of disseminated intravascular coagulation
(DIC)?
A. Elevated fibrinogen
B. Prolonged PT and aPTT with thrombocytopenia
C. Increased platelet count
D. Elevated D-dimer and low fibrinogen
Correct Answer: D. Elevated D-dimer and low fibrinogen
Rationale: Consumption of coagulation factors leads to low fibrinogen and elevated D-dimer. Elevated
fibrinogen is an acute phase reactant, not consistent with DIC. Prolonged PT/aPTT and
thrombocytopenia are suggestive but not diagnostic alone. Increased platelets would not occur in DIC.
Why Wrong:
A - Fibrinogen is elevated in acute phase, not consumed early; low fibrinogen is typical.
B - Prolonged PT/aPTT and thrombocytopenia are common but not specific without elevated
D-dimer.
C - Thrombocytopenia, not thrombocytosis, occurs in DIC.
Reference: Levi, M. (2020). Clinical practice: Disseminated intravascular coagulation. New England
Journal of Medicine.
Page 3
, Q5. A patient with acute pancreatitis has a Ranson criteria score of 4 at 48 hours. Which systemic
complication is most likely to develop?
A. Pancreatic pseudocyst
B. Acute respiratory distress syndrome (ARDS)
C. Chronic pancreatitis
D. Pancreatic abscess
Correct Answer: B. Acute respiratory distress syndrome (ARDS)
Rationale: Ranson score >3 indicates severe pancreatitis with high risk of organ failure, especially
pulmonary (ARDS). Pseudocyst and abscess are local complications occurring later. Chronic pancreatitis
is a long-term outcome.
Why Wrong:
A - Pseudocyst develops weeks later, not as an early systemic complication.
C - Chronic pancreatitis results from recurrent episodes, not acute phase.
D - Pancreatic abscess is a late infectious complication.
Reference: Banks, P.A., et al. (2021). Classification of acute pancreatitis-2012: revision of the Atlanta
classification. Gut.
Q6. A patient with acute decompensated heart failure has a pulmonary artery catheter showing
PCWP 24 mm Hg, cardiac output 4.2 L/min, and systemic vascular resistance (SVR) 1600
dynes-sec/cm5. Which pharmacologic intervention is most appropriate?
A. Sodium nitroprusside
B. Dobutamine
C. Furosemide
D. Milrinone
Correct Answer: A. Sodium nitroprusside
Rationale: High PCWP and high SVR indicate vasoconstriction; nitroprusside reduces both preload and
afterload, improving cardiac output and pulmonary congestion. Dobutamine increases contractility but
does not address high afterload. Furosemide reduces preload but not afterload. Milrinone has
vasodilatory effect but not first-line.
Why Wrong:
B - Dobutamine is indicated for low cardiac output with normal or low SVR; here SVR is high.
C - Furosemide diuresis reduces preload but does not significantly lower afterload.
D - Milrinone is a phosphodiesterase inhibitor with inotropic and vasodilatory effects but is
second-line due to arrhythmia risk.
Reference: Yancy, C.W., et al. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart
Failure. Circulation.
Page 4
Document | 2026/2027 Edition | 200 Verified Questions
NR 341 Complex Adult Health Exam 1 2026-2027 QUESTIONS AND ANSWERS ALREADY GRADED A+. 100%
Verified Solutions | Updated Per Latest Guidelines | Graded A+
This comprehensive exam preparation document covers Complex Adult Health Exam 1 for NR 341,
featuring 200 verified questions with detailed rationales. It is designed for nursing students seeking a
pass guarantee and A+ grading. Content reflects the latest 2026/2027 curriculum and clinical
guidelines. Each question includes evidence-based rationales to reinforce understanding of complex
adult health concepts.
Abstract:
NR 341 Complex Adult Health Exam 1 is a rigorous assessment of nursing students' ability to manage critically ill
adult patients. This document contains 200 actual exam questions from the 2026/2027 academic year, each with
detailed rationales that explain correct and incorrect answer choices. The content covers core areas such as
hemodynamic monitoring, mechanical ventilation, acute kidney injury, cardiac emergencies, neurological deficits,
and sepsis. Rationales are grounded in the latest evidence-based guidelines from organizations like the AACN and
AHA. This resource is designed to ensure students not only pass but achieve top scores by understanding the 'why'
behind each answer. It is ideal for self-study, group review, or as a supplement to course materials.
Content Area Overview:
Content Area Questions Key Topics Weight
Hemodynamics & Shock 1-40 Hemodynamic monitoring, shock 20%
classification, vasoactive medications, fluid
resuscitation
Respiratory Failure 41-80 ARDS, mechanical ventilation settings, 20%
ABG interpretation, weaning protocols
Renal & Electrolytes 81-120 Acute kidney injury, fluid/electrolyte 20%
imbalances, CRRT, acidosis/alkalosis
Cardiovascular Emergencies 121-150 ACS, dysrhythmias, cardiac tamponade, 15%
aortic dissection
Neurological Disorders 151-175 Stroke, intracranial pressure management, 12.5%
traumatic brain injury
Sepsis & MODS 176-200 Sepsis bundles, multi-organ dysfunction, 12.5%
vasopressors, steroids
Page 1
,Q1. A patient with septic shock remains hypotensive (MAP 58 mm Hg) despite norepinephrine at 30
mcg/min and vasopressin 0.04 units/min. Which intervention is most appropriate next?
A. Add dobutamine
B. Increase norepinephrine to 40 mcg/min
C. Start intravenous hydrocortisone
D. Add epinephrine infusion
Correct Answer: C. Start intravenous hydrocortisone
Rationale: Surviving Sepsis Campaign guidelines recommend intravenous hydrocortisone for
vasopressor-refractory septic shock. Dobutamine is indicated for low cardiac output, not as a
vasopressor. Increasing norepinephrine above moderate doses does not improve outcomes and may cause
adverse effects. Epinephrine is not first-line adjunct.
Why Wrong:
A - Dobutamine is not a vasopressor; it is used when cardiac output is low, which is not established.
B - Excessive norepinephrine doses increase risk of arrhythmias without proven benefit.
D - Epinephrine is reserved for anaphylaxis or refractory shock; not first-line adjunct for septic
shock.
Reference: Evans, L., et al. (2023). Surviving Sepsis Campaign: International Guidelines for
Management of Sepsis and Septic Shock 2021. Intensive Care Medicine.
Q2. A patient with ARDS on volume-controlled ventilation (FiO2 0.8, PEEP 12 cmH2O, tidal
volume 6 mL/kg PBW) has PaO2 70 mm Hg, PaCO2 48 mm Hg, pH 7.30. Which prescription is
anticipated, nonessential, or contraindicated?
A. Increase PEEP to 15 cmH2O
B. Administer cisatracurium infusion
C. Prone positioning
D. Decrease tidal volume to 4 mL/kg
Correct Answer: A. Increase PEEP to 15 cmH2O
Rationale: Increased PEEP (anticipated) may improve oxygenation; cisatracurium (anticipated) is
indicated for severe ARDS (PaO2/FiO2 <150); prone positioning (anticipated) improves oxygenation for
severe ARDS; decreasing Vt to 4 mL/kg is contraindicated as it worsens acidosis; inhaled nitric oxide is a
rescue therapy not routinely needed.
Reference: Thompson, B.T., et al. (2022). Acute Respiratory Distress Syndrome. New England Journal of
Medicine.
Page 2
,Q3. A patient with acute kidney injury stage 3 (serum creatinine 4.2 mg/dL, urine output <0.3
mL/kg/hr for 24 hours) has serum potassium of 6.8 mEq/L with broad QRS complexes on ECG.
Which intervention should be performed immediately?
A. Hemodialysis
B. Intravenous calcium gluconate
C. Sodium polystyrene sulfonate (Kayexalate)
D. Insulin and dextrose
Correct Answer: B. Intravenous calcium gluconate
Rationale: Calcium gluconate rapidly stabilizes the cardiac membrane in life-threatening hyperkalemia
with ECG changes. Insulin/dextrose and dialysis shift/remove potassium but are not first for acute
arrhythmia risk. Kayexalate is slow and not useful in emergency.
Why Wrong:
A - Hemodialysis effectively removes potassium but takes time to arrange; not the immediate
priority.
C - Sodium polystyrene sulfonate has delayed onset and is not indicated for acute hyperkalemia with
ECG changes.
D - Insulin and dextrose shifts potassium into cells but does not immediately protect the heart.
Reference: KDIGO. (2024). Clinical Practice Guideline for Acute Kidney Injury. Kidney International
Supplements.
Q4. A patient with septic shock develops widespread petechiae and bleeding from mucous
membranes. Which laboratory finding is most diagnostic of disseminated intravascular coagulation
(DIC)?
A. Elevated fibrinogen
B. Prolonged PT and aPTT with thrombocytopenia
C. Increased platelet count
D. Elevated D-dimer and low fibrinogen
Correct Answer: D. Elevated D-dimer and low fibrinogen
Rationale: Consumption of coagulation factors leads to low fibrinogen and elevated D-dimer. Elevated
fibrinogen is an acute phase reactant, not consistent with DIC. Prolonged PT/aPTT and
thrombocytopenia are suggestive but not diagnostic alone. Increased platelets would not occur in DIC.
Why Wrong:
A - Fibrinogen is elevated in acute phase, not consumed early; low fibrinogen is typical.
B - Prolonged PT/aPTT and thrombocytopenia are common but not specific without elevated
D-dimer.
C - Thrombocytopenia, not thrombocytosis, occurs in DIC.
Reference: Levi, M. (2020). Clinical practice: Disseminated intravascular coagulation. New England
Journal of Medicine.
Page 3
, Q5. A patient with acute pancreatitis has a Ranson criteria score of 4 at 48 hours. Which systemic
complication is most likely to develop?
A. Pancreatic pseudocyst
B. Acute respiratory distress syndrome (ARDS)
C. Chronic pancreatitis
D. Pancreatic abscess
Correct Answer: B. Acute respiratory distress syndrome (ARDS)
Rationale: Ranson score >3 indicates severe pancreatitis with high risk of organ failure, especially
pulmonary (ARDS). Pseudocyst and abscess are local complications occurring later. Chronic pancreatitis
is a long-term outcome.
Why Wrong:
A - Pseudocyst develops weeks later, not as an early systemic complication.
C - Chronic pancreatitis results from recurrent episodes, not acute phase.
D - Pancreatic abscess is a late infectious complication.
Reference: Banks, P.A., et al. (2021). Classification of acute pancreatitis-2012: revision of the Atlanta
classification. Gut.
Q6. A patient with acute decompensated heart failure has a pulmonary artery catheter showing
PCWP 24 mm Hg, cardiac output 4.2 L/min, and systemic vascular resistance (SVR) 1600
dynes-sec/cm5. Which pharmacologic intervention is most appropriate?
A. Sodium nitroprusside
B. Dobutamine
C. Furosemide
D. Milrinone
Correct Answer: A. Sodium nitroprusside
Rationale: High PCWP and high SVR indicate vasoconstriction; nitroprusside reduces both preload and
afterload, improving cardiac output and pulmonary congestion. Dobutamine increases contractility but
does not address high afterload. Furosemide reduces preload but not afterload. Milrinone has
vasodilatory effect but not first-line.
Why Wrong:
B - Dobutamine is indicated for low cardiac output with normal or low SVR; here SVR is high.
C - Furosemide diuresis reduces preload but does not significantly lower afterload.
D - Milrinone is a phosphodiesterase inhibitor with inotropic and vasodilatory effects but is
second-line due to arrhythmia risk.
Reference: Yancy, C.W., et al. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart
Failure. Circulation.
Page 4
